Men with Stage IV breast cancer and known estrogen (ER) and progesterone receptor (PR) status benefit from surgical intervention and from trimodal therapy (systemic therapy, surgery, and radiation), according to a study presented at the virtual American College of Surgeons…
Read More
Long-term survival improving for kidney transplant patients
If you’re a kidney transplant patient, your chances of living a longer life are improving. That’s according to a recent review published in The New England Journal of Medicine. It showed that the five-year survival rate of transplant recipients who…
Read More
Survival similar for younger and older patients with metastatic colorectal cancer, study finds
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute…
Read More
Long-term survival rates for immunotherapies could be misinterpreted
Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology. The study, “Development and Evaluation of…
Read More
Mutations in overlooked DNA could have profound impact on survival for bowel cancer patients
Mutations in the DNA of the cell’s energy ‘factories’ increases the chances of survival for people with bowel cancer, according to a study published today in Nature Metabolism. Scientists funded by Cancer Research UK have found that patients with colorectal…
Read More
Early ECMO-facilitated resuscitation ups survival in OHCA
(HealthDay)—Early extracorporeal membrane oxygenation (ECMO)-facilitated resuscitation improves survival to hospital discharge compared with standard advanced cardiac life support (ACLS) for adults with out-of-hospital cardiac arrest (OHCA) and refractory ventricular fibrillation, according to a study published online Nov. 13 in The…
Read More
Investigational ALS drug prolongs patient survival in clinical trial
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial…
Read More
New therapy extends breast cancer survival rate, prevents reoccurrence
A new immunotherapy developed by researchers at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer. In a new study, mice treated with the…
Read More
Brain tumor surgery that pushes boundaries boosts patients survival
Survival may more than double for adults with glioblastoma, the most common and deadly type of brain tumor, if neurosurgeons remove the surrounding tissue as aggressively as they remove the cancerous core of the tumor. This discovery, reported in a…
Read More